Boston Scientific (BSX) Invested Capital (2009 - 2026)

Boston Scientific (BSX) has 18 years of Invested Capital data on file, last reported at $41.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 99.64% year-over-year to $41.0 million; the trailing twelve-month figure through Mar 2026 stood at $23.5 billion (down 45.93% YoY), and the FY2025 full-year result was $299.0 million, down 97.22% from the prior year.
• Invested Capital declined to $41.0 million in Q1 2026, from $299.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $11.6 billion in Q3 2025 to a low of $41.0 million in Q1 2026.
• A 5-year average of $8.8 billion and a median of $9.1 billion in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital increased 22.3% in 2024 and tumbled 99.64% in 2026, its largest moves.
• Tracing BSX's Invested Capital over 5 years: stood at $8.9 billion in 2022, then gained by 1.87% to $9.1 billion in 2023, then gained by 18.06% to $10.7 billion in 2024, then tumbled by 97.22% to $299.0 million in 2025, then slumped by 86.29% to $41.0 million in 2026.
• Business Quant data shows BSX's Invested Capital at $41.0 million in Q1 2026, $299.0 million in Q4 2025, and $11.6 billion in Q3 2025.